Refine by
Infection Resistant Articles & Analysis
57 news found
The Centers for Disease Control and Prevention (CDC) reports there are an estimated 450,000 cases of shigellosis, an infection caused by Shigella bacteria, in the United States each year. Unfortunately, a growing number of these infections involve drug-resistant Shigella. The four species of Shigella listed by the CDC include: Shigella sonnei ...
“Antimicrobial peptides have immense potential in addressing one of the most urgent challenges of our time—antibiotic resistance,” said Crystal, the Chief Marketing staff at Profacgen. ...
Antibacterial Serum Preparation Bacterial infections remain a significant concern globally, and the emergence of antibiotic-resistant strains has heightened this challenge. ...
The Centers for Disease Control and Prevention (CDC) warns these bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat those infections. Vancomycin-resistant enterococci (VRE) is the name for the bacteria resistant to the antibiotic known as vancomycin. When the CDC released the 2019 Antibiotic ...
XF-73 Nasal targeting peak sales potential of $1 billion in its major target markets Phase 3 patient recruitment could start in 2024 subject to completing an XF-73 Nasal partnering deal in 2023 XF-73 Nasal is the lead drug candidate developed from Destiny Pharma’s XF platform and it is initially being developed for the prevention of post-surgical staphylococcal ...
The objective of this research program is unique in that its goal is to prevent infections rather than treat them after they have already taken hold. This preventative approach will allow Lumen to develop an inexpensive, biologic drug cocktail against the most frequent, multi-drug resistant infecting pathogens. The therapeutic product would be ...
First, to raise specific immunity against one of the most important antibiotic-resistant bacteria in humans populations at hjgh-risk of development of antibiotic-resistant infections. And second, deliver to the porcine industry a vaccine to prevent infections of one of the most important causative agents of respiratory diseases ...
More than 2.8 million antibiotic-resistant infections occur in the U.S. each year and more than 35,000 people die as a result according to the CDC’s 2019 Antibiotic Resistance (AR) Threats Report. ...
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi Ondine’s nonantibiotic photodisinfection technology has been proven in Canadian hospitals to kill pathogens helping to generate 84% reduction of postoperative infection ...
In this publication titled “Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalized patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomized controlled trial1,” the authors assessed the clinical utility and impact of the Unyvero panel in hospitalized adult patients with ...
To help curb the global spread of antimicrobial resistance (AMR) pathogens, Ares Genetics is expanding its commercial offering of sequencing and analysis services aimed at clinical microbiologists and specialists in public health and infection prevention and control. ...
(Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that its subsidiary, Ares Genetics (Ares), which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), is expanding its strategic collaboration ...
A well known imaging side effect is exposure to radiation through an X Ray or CT scan potentially leading to the patient becoming unwell and having a low resistance to infection. Using a portable scanner increases patient safety by lowering the risk of adverse health effects. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced it has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform. ...
The emergence and spread of drug-resistant pathogens that have acquired new resistance mechanisms, leading to antimicrobial resistance, continues to threaten to impair our ability to treat common infections. There is concern that the rapid global spread of multi-drug-resistant and ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that John Wilson has joined the company as Chief Commercial Officer. ...
The KapaVax candidate targets include three of the most worrisome antibiotic-resistant bacteria of the list of the WHO: Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, for which there are not available vaccines yet. The primary target population in need will be individuals affected by chronic lung problems in high risk of developing ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that it has received a $2.8 million award from the U.S. ...
Specific Diagnostics announces today the commencement of its US clinical studies for the Reveal Rapid AST System for blood infection. Trials will entail 3 months of data collection followed by submission for FDA consideration of 510(k) clearance of the Reveal test. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. ...